Chapter/Section Purchase

1 Study Coverage
1.1 Subcutaneous Immunoglobulins Product Introduction
1.2 Market by Purity
1.2.1 Global Subcutaneous Immunoglobulins Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028
1.2.2 0.1
1.2.3 0.2
1.3 Market by Application
1.3.1 Global Subcutaneous Immunoglobulins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Subcutaneous Immunoglobulins Sales Estimates and Forecasts 2017-2028
2.2 Global Subcutaneous Immunoglobulins Revenue Estimates and Forecasts 2017-2028
2.3 Global Subcutaneous Immunoglobulins Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Subcutaneous Immunoglobulins Sales by Region
2.4.1 Global Subcutaneous Immunoglobulins Sales by Region (2017-2022)
2.4.2 Global Sales Subcutaneous Immunoglobulins by Region (2023-2028)
2.5 Global Subcutaneous Immunoglobulins Revenue by Region
2.5.1 Global Subcutaneous Immunoglobulins Revenue by Region (2017-2022)
2.5.2 Global Subcutaneous Immunoglobulins Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Subcutaneous Immunoglobulins Sales by Manufacturers
3.1.1 Global Top Subcutaneous Immunoglobulins Manufacturers by Sales (2017-2022)
3.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Subcutaneous Immunoglobulins in 2021
3.2 Global Subcutaneous Immunoglobulins Revenue by Manufacturers
3.2.1 Global Subcutaneous Immunoglobulins Revenue by Manufacturers (2017-2022)
3.2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Immunoglobulins Revenue in 2021
3.3 Global Subcutaneous Immunoglobulins Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Subcutaneous Immunoglobulins Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Purity
4.1 Global Subcutaneous Immunoglobulins Sales by Purity
4.1.1 Global Subcutaneous Immunoglobulins Historical Sales by Purity (2017-2022)
4.1.2 Global Subcutaneous Immunoglobulins Forecasted Sales by Purity (2023-2028)
4.1.3 Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2028)
4.2 Global Subcutaneous Immunoglobulins Revenue by Purity
4.2.1 Global Subcutaneous Immunoglobulins Historical Revenue by Purity (2017-2022)
4.2.2 Global Subcutaneous Immunoglobulins Forecasted Revenue by Purity (2023-2028)
4.2.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2017-2028)
4.3 Global Subcutaneous Immunoglobulins Price by Purity
4.3.1 Global Subcutaneous Immunoglobulins Price by Purity (2017-2022)
4.3.2 Global Subcutaneous Immunoglobulins Price Forecast by Purity (2023-2028)
5 Market Size by Application
5.1 Global Subcutaneous Immunoglobulins Sales by Application
5.1.1 Global Subcutaneous Immunoglobulins Historical Sales by Application (2017-2022)
5.1.2 Global Subcutaneous Immunoglobulins Forecasted Sales by Application (2023-2028)
5.1.3 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2028)
5.2 Global Subcutaneous Immunoglobulins Revenue by Application
5.2.1 Global Subcutaneous Immunoglobulins Historical Revenue by Application (2017-2022)
5.2.2 Global Subcutaneous Immunoglobulins Forecasted Revenue by Application (2023-2028)
5.2.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2017-2028)
5.3 Global Subcutaneous Immunoglobulins Price by Application
5.3.1 Global Subcutaneous Immunoglobulins Price by Application (2017-2022)
5.3.2 Global Subcutaneous Immunoglobulins Price Forecast by Application (2023-2028)
6 North America
6.1 North America Subcutaneous Immunoglobulins Market Size by Purity
6.1.1 North America Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
6.1.2 North America Subcutaneous Immunoglobulins Revenue by Purity (2017-2028)
6.2 North America Subcutaneous Immunoglobulins Market Size by Application
6.2.1 North America Subcutaneous Immunoglobulins Sales by Application (2017-2028)
6.2.2 North America Subcutaneous Immunoglobulins Revenue by Application (2017-2028)
6.3 North America Subcutaneous Immunoglobulins Market Size by Country
6.3.1 North America Subcutaneous Immunoglobulins Sales by Country (2017-2028)
6.3.2 North America Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Subcutaneous Immunoglobulins Market Size by Purity
7.1.1 Europe Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
7.1.2 Europe Subcutaneous Immunoglobulins Revenue by Purity (2017-2028)
7.2 Europe Subcutaneous Immunoglobulins Market Size by Application
7.2.1 Europe Subcutaneous Immunoglobulins Sales by Application (2017-2028)
7.2.2 Europe Subcutaneous Immunoglobulins Revenue by Application (2017-2028)
7.3 Europe Subcutaneous Immunoglobulins Market Size by Country
7.3.1 Europe Subcutaneous Immunoglobulins Sales by Country (2017-2028)
7.3.2 Europe Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Subcutaneous Immunoglobulins Market Size by Purity
8.1.1 Asia Pacific Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
8.1.2 Asia Pacific Subcutaneous Immunoglobulins Revenue by Purity (2017-2028)
8.2 Asia Pacific Subcutaneous Immunoglobulins Market Size by Application
8.2.1 Asia Pacific Subcutaneous Immunoglobulins Sales by Application (2017-2028)
8.2.2 Asia Pacific Subcutaneous Immunoglobulins Revenue by Application (2017-2028)
8.3 Asia Pacific Subcutaneous Immunoglobulins Market Size by Region
8.3.1 Asia Pacific Subcutaneous Immunoglobulins Sales by Region (2017-2028)
8.3.2 Asia Pacific Subcutaneous Immunoglobulins Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Subcutaneous Immunoglobulins Market Size by Purity
9.1.1 Latin America Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
9.1.2 Latin America Subcutaneous Immunoglobulins Revenue by Purity (2017-2028)
9.2 Latin America Subcutaneous Immunoglobulins Market Size by Application
9.2.1 Latin America Subcutaneous Immunoglobulins Sales by Application (2017-2028)
9.2.2 Latin America Subcutaneous Immunoglobulins Revenue by Application (2017-2028)
9.3 Latin America Subcutaneous Immunoglobulins Market Size by Country
9.3.1 Latin America Subcutaneous Immunoglobulins Sales by Country (2017-2028)
9.3.2 Latin America Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Subcutaneous Immunoglobulins Market Size by Purity
10.1.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
10.1.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Purity (2017-2028)
10.2 Middle East and Africa Subcutaneous Immunoglobulins Market Size by Application
10.2.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2017-2028)
10.2.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Application (2017-2028)
10.3 Middle East and Africa Subcutaneous Immunoglobulins Market Size by Country
10.3.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2017-2028)
10.3.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shire (Baxalta)
11.1.1 Shire (Baxalta) Corporation Information
11.1.2 Shire (Baxalta) Overview
11.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shire (Baxalta) Recent Developments
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Overview
11.2.3 Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Grifols Subcutaneous Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Overview
11.3.3 CSL Subcutaneous Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CSL Subcutaneous Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Subcutaneous Immunoglobulins Industry Chain Analysis
12.2 Subcutaneous Immunoglobulins Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Subcutaneous Immunoglobulins Production Mode & Process
12.4 Subcutaneous Immunoglobulins Sales and Marketing
12.4.1 Subcutaneous Immunoglobulins Sales Channels
12.4.2 Subcutaneous Immunoglobulins Distributors
12.5 Subcutaneous Immunoglobulins Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Subcutaneous Immunoglobulins Industry Trends
13.2 Subcutaneous Immunoglobulins Market Drivers
13.3 Subcutaneous Immunoglobulins Market Challenges
13.4 Subcutaneous Immunoglobulins Market Restraints
14 Key Findings in The Global Subcutaneous Immunoglobulins Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer